ClinicalTrials.gg
Drug

ON 01910 clinical trials

Also written ON 01910.Na, rigosertib and SyB C-1101.

studies test it
36
open now
0
in phase 3
4
first study started
2006

How each study uses ON 01910 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

oral rigosertib
4
ON 01910.Na Concentrate
3

Development codes

ON 01910.Na
23
SyB C-1101
3

Other names

rigosertib
17
rigosertib sodium
15

Studies by the year they started

36 studies that test it; most in 2009 (7)

Studies that test ON 01910, by start year
YearStudies
20062
20071
20083
20097
20104
20111
20121
20136
20143
20152
20172
20201
20212
20231

Who runs them

Industry 29 · Other 7

Traws Pharma, Inc. (25) · SymBio Pharmaceuticals (4) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Prof. Johann Bauer (1) · Thomas Jefferson University (1) · Icahn School of Medicine at Mount Sinai (1) · Vanderbilt-Ingram Cancer Center (1) · M.D. Anderson Cancer Center (1)

Often tested with

Tested in the same studies.

Gemcitabine (1)

Studies

Open first, then newest update. How each study uses ON 01910 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 36

See all 36 studies that test ON 01910 →

Codes

What other systems call ON 01910 · ClinicalTrials.gg INT004867

  • MeSH (NLM) C507134ON 01910Confirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 406FL5G00VRIGOSERTIB SODIUMConfirmed FDA, NLM

Also registered as rigosertib (UNII 67DOW7F9GL).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.